Intraocular injection of anti-vegf for the treatment of intraocular tumors

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OPC-15006393

Enrollment

Unknown

Registered

2015-05-13

Start date

2015-05-14

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intraocular tumor

Interventions

treatment:intraocular anti-vegf

Eligibility

Sex/Gender

All

Age

No minimum to 80 Years

Inclusion criteria

Inclusion criteria: 1. Intraocular tumor that cause visual decrease; 2. Primary tumors that have progression or with complications; 3. Metastatic tumors with the primary foci controlled; 4. Systemic condition is fine; 5. Signed consent forms obtained.

Exclusion criteria

Exclusion criteria: 1. Deterioration of systemic condition; 2. Tendency of ocular atrophy.

Design outcomes

Primary

Measure	Time frame
visual acuity;Tumour size;	—

Secondary

Measure	Time frame
images;	—

Countries

China

Contacts

Public ContactXuejiao Qin

qinxuejiao@hotmail.com+86 13505311019

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026